Evidence map›Paper›PMID 30879339›Full record

ReviewCirculation2019

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Donna K Arnett, Roger S Blumenthal, Michelle A Albert, Andrew B Buroker, Zachary D Goldberger, Ellen J Hahn, Cheryl Dennison Himmelfarb, Amit Khera, Donald Lloyd-Jones, J William McEvoy and 8 more

Erratum issued Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05693857 (Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Willingness to Follow Recommendations for Cardiovascular Prevention), which is not on this map. Cited by 603 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
603citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05693857 recruitingnot on this mapstarted 2023, after this paper: background citation

Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Willingness to Follow Recommendations for Cardiovascular Prevention

Typeobservational_patient_registrySponsorChinese University of Hong KongRan2023 to 2028Enrolled1,500ConditionsPatient-Perceived VersusArmsCardiovascular prevention guidelines
3 · Its place in the literature

Who cites it

603 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Pooled it
  2. A systematic review of causal pathways of socioeconomic inequalities in stroke.International journal of stroke : official journal of the International Stroke Society · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Early atherogenesis: In search of etiology.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

543 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Donna K Arnett
Roger S Blumenthal
Michelle A AlbertACC/AHA Representative.
Andrew B BurokerLay Representative.
Zachary D GoldbergerACC/AHA Task Force on Clinical Practice Guidelines Liaison.
Ellen J HahnACC/AHA Representative.
Cheryl Dennison HimmelfarbACC/AHA Representative.
Amit KheraACC/AHA Representative.
Donald Lloyd-JonesACC/AHA Representative.
J William McEvoyACC/AHA Representative.
Erin D MichosACC/AHA Representative.
Michael D MiedemaACC/AHA Representative.
Daniel MuñozACC/AHA Representative.
Sidney C SmithACC/AHA Representative.
Salim S ViraniACC/AHA Representative.
Kim A WilliamsACC/AHA Representative.
Joseph YeboahACC/AHA Representative.
Boback ZiaeianTask Force Performance Measures Representative.

Funding

Institutional Career Development CoreKL2TR001882 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$1.0M
American Heart Association-American Stroke Association 17SDG33630113NCATS NIH HHS KL2 TR001882
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

American Heart AssociationAdvisory CommitteesCardiologyCardiovascular DiseasesHumansPractice Guidelines as TopicPrimary PreventionResearch ReportRisk Reduction BehaviorUnited StatesAHA Scientific Statementsantihypertensive agentsaspirinatherosclerosisatherosclerotic cardiovascular diseaseatrial fibrillationbehavior modificationbehavior therapyblood cholesterolblood pressurebody mass indexcardiovascularcardiovascular diseasecardiovascular team-based carecholesterolchronic kidney diseasecoronary artery calcium scorecoronary diseasecoronary heart diseasecostdiabetes mellitusdietdietary fatsdietary patternsdietary sodiumdyslipidemiae-cigarettesexerciseguidelineshealthcare disparitieshealth services accessibilityheart failurehypertensionLDL cholesterollifestylelipidsmeasurementmyocardial infarctionnicotinenonpharmacological treatmentnutritionphysical activityprejudiceprimary preventionpsychosocial deprivationpublic healthquality indicatorsquality measurementrisk assessmentrisk-enhancing factorsrisk factorsrisk reductionrisk reduction discussionrisk treatment discussionsecondhand smokesleepsmokingsmoking cessationsocial determinants of healthsocioeconomic factorsstatin therapysystems of caretobaccotobacco smoke pollutiontreatment adherencetreatment outcomestype 2 diabetes mellituswaist circumferenceweight loss

Identifiers

PMID30879339
PMCPMC8351755

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.